VF arrest secondary to immune checkpoint inhibitor (ICI)-associated myocarditis; improving patient outcomes by maintaining a high clinical suspicion for ICI toxicity

VF arrest secondary to immune checkpoint inhibitor (ICI)-associated myocarditis; improving patient outcomes by maintaining a high clinical suspicion for ICI toxicity

Introduction: Use of immune checkpoint inhibitor (ICI) medications has revolutionised clinical outcomes and remains an exciting prospect in oncology as further indications are revealed.1 However, adverse effects, or toxicities, secondary to their non-targeted immunological activation create an array...

Full description

Saved in:
Bibliographic Details
Main Author: Victoria Floyd-Ellis
Format: Article
Language:English
Published: Elsevier 2025-07-01
Series:Clinical Medicine
Online Access:http://www.sciencedirect.com/science/article/pii/S1470211825002015
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items

Similar Items